156 related articles for article (PubMed ID: 29857274)
1. A bioactive implant in situ and long-term releases combined drugs for treatment of osteoarticular tuberculosis.
Zhou CX; Li L; Ma YG; Li BN; Li G; Zhou Z; Shi F; Weng J; Zhang C; Wang F; Cui X; Wang L; Wang H
Biomaterials; 2018 Sep; 176():50-59. PubMed ID: 29857274
[TBL] [Abstract][Full Text] [Related]
2. Instant hydrogelation encapsulates drugs onto implants intraoperatively against osteoarticular tuberculosis.
Li Y; Li L; Sha X; Zhang K; Li G; Ma Y; Zhou J; Hao Y; Zhang Z; Cui X; Tang PF; Wang L; Wang H
J Mater Chem B; 2021 Oct; 9(38):8056-8066. PubMed ID: 34491255
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-assisted fixation of drug-loaded polymeric multilayers to osteoarticular implants for tuberculosis therapy.
Li D; Li L; Ma Y; Zhuang Y; Li D; Shen H; Wang X; Yang F; Ma Y; Wu D
Biomater Sci; 2017 Mar; 5(4):730-740. PubMed ID: 28218329
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid conjugated poly(lactide-co-glycolide): long-term controlled drug release and tissue regeneration for bone tuberculosis therapy.
Huang D; Li D; Wang T; Shen H; Zhao P; Liu B; You Y; Ma Y; Yang F; Wu D; Wang S
Biomaterials; 2015 Jun; 52():417-25. PubMed ID: 25818448
[TBL] [Abstract][Full Text] [Related]
5. 3D-printed hierarchical scaffold for localized isoniazid/rifampin drug delivery and osteoarticular tuberculosis therapy.
Zhu M; Li K; Zhu Y; Zhang J; Ye X
Acta Biomater; 2015 Apr; 16():145-55. PubMed ID: 25653217
[TBL] [Abstract][Full Text] [Related]
6. A biphasic nanohydroxyapatite/calcium sulphate carrier containing Rifampicin and Isoniazid for local delivery gives sustained and effective antibiotic release and prevents biofilm formation.
Qayoom I; Verma R; Murugan PA; Raina DB; Teotia AK; Matheshwaran S; Nair NN; Tägil M; Lidgren L; Kumar A
Sci Rep; 2020 Aug; 10(1):14128. PubMed ID: 32839480
[TBL] [Abstract][Full Text] [Related]
7. A thermo-responsive and self-healing liposome-in-hydrogel system as an antitubercular drug carrier for localized bone tuberculosis therapy.
Liu P; Guo B; Wang S; Ding J; Zhou W
Int J Pharm; 2019 Mar; 558():101-109. PubMed ID: 30634030
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and in vitro cytotoxicity evaluation of a novel anti-tuberculosis reconstruction implant.
Dong J; Zhang S; Ma J; Liu H; Du Y; Liu Y
PLoS One; 2014; 9(4):e94937. PubMed ID: 24740373
[TBL] [Abstract][Full Text] [Related]
9. Development and in vitro characterization of rifapentine microsphere-loaded bone implants: a sustained drug delivery system.
Wang Z; Song X; Yang H; Maimaitiaili A; Wang T
Ann Palliat Med; 2020 Mar; 9(2):375-387. PubMed ID: 32233632
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of bioactive rifampicin loaded κ-Car-MA-INH/Nano hydroxyapatite composite for tuberculosis osteomyelitis infected tissue regeneration.
Amarnath Praphakar R; Sumathra M; Sam Ebenezer R; Vignesh S; Shakila H; Rajan M
Int J Pharm; 2019 Jun; 565():543-556. PubMed ID: 31102805
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensionally plotted MBG/PHBHHx composite scaffold for antitubercular drug delivery and tissue regeneration.
Li K; Zhu M; Xu P; Xi Y; Cheng Z; Zhu Y; Ye X
J Mater Sci Mater Med; 2015 Feb; 26(2):102. PubMed ID: 25655503
[TBL] [Abstract][Full Text] [Related]
12. A mesoporous silica nanoparticulate/β-TCP/BG composite drug delivery system for osteoarticular tuberculosis therapy.
Zhu M; Wang H; Liu J; He H; Hua X; He Q; Zhang L; Ye X; Shi J
Biomaterials; 2011 Mar; 32(7):1986-95. PubMed ID: 21163519
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
Vilchèze C; Kim J; Jacobs WR
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29298757
[TBL] [Abstract][Full Text] [Related]
14. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy.
Wu W; Zheng Q; Guo X; Sun J; Liu Y
Biomed Mater; 2009 Dec; 4(6):065005. PubMed ID: 19901446
[TBL] [Abstract][Full Text] [Related]
15. Fabrication and characterization of hydroxypropyl guar-poly (vinyl alcohol)-nano hydroxyapatite composite hydrogels for bone tissue engineering.
Parameswaran-Thankam A; Al-Anbaky Q; Al-Karakooly Z; RanguMagar AB; Chhetri BP; Ali N; Ghosh A
J Biomater Sci Polym Ed; 2018 Dec; 29(17):2083-2105. PubMed ID: 29962278
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Polyphenolic Profile and Antibacterial Activity of Pomegranate Juice in Combination with Rifampin (R) against MDR-TB Clinical Isolates.
AlMatar M; Var I; Kayar B; Eker E; Kafkas E; Zarifikhosroshahi M; Köksal F
Curr Pharm Biotechnol; 2019; 20(4):317-326. PubMed ID: 30854955
[TBL] [Abstract][Full Text] [Related]
17. A mesoporous silicon/poly-(DL-lactic-co-glycolic) acid microsphere for long time anti-tuberculosis drug delivery.
Xu W; Wei X; Wei K; Cao X; Zhong S
Int J Pharm; 2014 Dec; 476(1-2):116-23. PubMed ID: 25271077
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
[TBL] [Abstract][Full Text] [Related]
19. Bone penetration of linezolid in osteoarticular tuberculosis patients of China.
Wen S; Zhang T; Yu X; Dong W; Lan T; Fan J; Xue Y; Wang F; Dong L; Qin S; Huang H
Int J Infect Dis; 2021 Feb; 103():364-369. PubMed ID: 33278623
[TBL] [Abstract][Full Text] [Related]
20. Could high-concentration rifampicin kill rifampicin-resistant M. tuberculosis? Rifampicin MIC test in rifampicin-resistant isolates from patients with osteoarticular tuberculosis.
Zhang Z; Dai F; Luo F; Zhong M; Huang Z; Hou T; Xu J
J Orthop Surg Res; 2014 Dec; 9():124. PubMed ID: 25467069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
